Fragment-based-Drug-Discovery-Market-Dynamics-Regional-Analysis
Fragment-based drug discovery (FBDD) represents a sophisticated and growing approach in contemporary drug development, centering on the identification of small chemical fragments as initial candidates for creating highly effective therapeutic compounds. Unlike traditional high-throughput screening (HTS), which evaluates extensive libraries of complex molecules, FBDD focuses on smaller libraries of low-molecular-weight fragments that exhibit weak but efficient binding to biological targets